Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and beauty - South Korea's famous face-lifting needle was revoked. Why was this face-lifting needle revoked?
South Korea's famous face-lifting needle was revoked. Why was this face-lifting needle revoked?
A few days ago, South Korea's US Food and Drug Administration (KFDA) revoked the license of a face-lifting needle product of a well-known biopharmaceutical company in South Korea. This measure will take effect from tomorrow (26th), and related products are also circulating in China market.

Which product was withdrawn this time and why?

This time, the license revoked by the US Food and Drug Administration (KFDA) in South Korea is the botulinum toxin Innotox type A produced by the Korean company Medto, which came into effect on the 26th of this month. South Korea's US Food and Drug Administration (KFDA) said that according to the investigation by the procuratorate, the company forged experimental materials in the process of applying for and changing the Innotox drug license, which violated relevant laws. On February 22 last year, 65438, South Korea's US Food and Drug Administration (KFDA) ordered Medtronic to suspend the production and sales of related products, and asked enterprises to recall or destroy products in circulation.

Botulinum toxin, also known as botulinum toxin and botulinum toxin, is the ingredient of the face-lifting needle that people often say. Widely used in cosmetic plastic surgery, it has the effect of improving wrinkles and thin face. Based on 20 19 years, the market size of Korean botulinum toxin reached150 billion won, or about 880 million yuan. As the first company licensed for botulinum toxin in Korea, Medtronic's market share reached 36%. On 18 this month, when the North Korean Food and Drug Administration (KFDA) made the relevant decision, Medtronic's share price closed down 1 1.33%.

Up to now, all three botulinum toxin products under Medtronic, except Innotox this time and Meditoxin and Coretox whose licenses were revoked last year, have been revoked by the US Food and Drug Administration (KFDA). In related industries in China, Medtronic has also been translated into Medrol.

Although Dumei botulinum toxin products have been exported to some countries and regions in the world, these three botulinum toxin products have not been approved by China National Medical Products Administration. It should be noted that these three botulinum toxin products have been used in some domestic beauty salons and other non-medical institutions through purchasing and other channels.

Remind consumers to pay more attention when choosing botulinum toxin products.